1. Home
  2. GME vs SCLXW Comparison

GME vs SCLXW Comparison

Compare GME & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GameStop Corporation

GME

GameStop Corporation

HOLD

Current Price

$22.11

Market Cap

11.8B

ML Signal

HOLD

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

HOLD

Current Price

$0.16

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GME
SCLXW
Founded
1996
N/A
Country
United States
United States
Employees
N/A
31
Industry
Electronics Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
N/A
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
GME
SCLXW
Price
$22.11
$0.16
Analyst Decision
Sell
Analyst Count
1
0
Target Price
$13.50
N/A
AVG Volume (30 Days)
6.3M
4.0K
Earning Date
12-09-2025
03-07-2025
Dividend Yield
N/A
N/A
EPS Growth
387.37
N/A
EPS
0.83
N/A
Revenue
$3,808,200,000.00
$55,152,000.00
Revenue This Year
$9.86
N/A
Revenue Next Year
$2.83
N/A
P/E Ratio
$25.66
N/A
Revenue Growth
N/A
22.02
52 Week Low
$19.93
$0.18
52 Week High
$35.81
$0.18

Technical Indicators

Market Signals
Indicator
GME
SCLXW
Relative Strength Index (RSI) 49.71 41.02
Support Level $21.50 $0.17
Resistance Level $24.00 $0.21
Average True Range (ATR) 0.83 0.03
MACD 0.01 -0.00
Stochastic Oscillator 49.46 30.64

Price Performance

Historical Comparison
GME
SCLXW

About GME GameStop Corporation

GameStop Corp is a U.S. multichannel video game, consumer electronics, and services retailer. The company operates across Europe, Canada, Australia, and the United States. The company sells new and second-hand video game hardware, physical and digital video game software, and video game accessories, mainly through GameStop, EB Games, and Micromania stores and international e-commerce sites. The majority of sales are from the United States. The company categorizes its products in three categories: Hardware and accessories, Software, and Collectibles. The company generates the majority of its revenue from the sale of Hardware and accessories products.

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: